AU2001273629A1 - Modulated release particles for lung delivery - Google Patents

Modulated release particles for lung delivery

Info

Publication number
AU2001273629A1
AU2001273629A1 AU2001273629A AU7362901A AU2001273629A1 AU 2001273629 A1 AU2001273629 A1 AU 2001273629A1 AU 2001273629 A AU2001273629 A AU 2001273629A AU 7362901 A AU7362901 A AU 7362901A AU 2001273629 A1 AU2001273629 A1 AU 2001273629A1
Authority
AU
Australia
Prior art keywords
release particles
lung delivery
modulated release
modulated
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273629A
Other languages
English (en)
Inventor
Akwete L. Adjei
Anthony J. Cutie
John Z. Sun
Yaping Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeropharm Technology LLC
Original Assignee
Aeropharm Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeropharm Technology LLC filed Critical Aeropharm Technology LLC
Publication of AU2001273629A1 publication Critical patent/AU2001273629A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001273629A 2000-07-18 2001-06-25 Modulated release particles for lung delivery Abandoned AU2001273629A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21905100P 2000-07-18 2000-07-18
US60219051 2000-07-18
US09702894 2000-10-31
US09/702,894 US6669959B1 (en) 2000-07-18 2000-10-31 Modulated release particles for lung delivery
PCT/US2001/041120 WO2002005730A1 (fr) 2000-07-18 2001-06-25 Particules a liberation modulee administrees par voie pulmonaire

Publications (1)

Publication Number Publication Date
AU2001273629A1 true AU2001273629A1 (en) 2002-01-30

Family

ID=26913515

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273629A Abandoned AU2001273629A1 (en) 2000-07-18 2001-06-25 Modulated release particles for lung delivery

Country Status (3)

Country Link
US (1) US6669959B1 (fr)
AU (1) AU2001273629A1 (fr)
WO (1) WO2002005730A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003243191B2 (en) * 2002-05-02 2007-09-20 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
WO2006078320A2 (fr) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Procede de production de systemes d'administration, et systemes d'administration
US20060057216A1 (en) * 2004-09-15 2006-03-16 Salamone Joseph C Low-obscuration image transmitting particulate ocular therapeutic formulations
US7495052B2 (en) * 2004-09-15 2009-02-24 Bausch & Lomb Incorporated Method for the production of polymerized nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
US7879361B2 (en) * 2005-01-04 2011-02-01 Gp Medical, Inc. Nanoparticles for drug delivery
US20070120281A1 (en) * 2005-11-08 2007-05-31 Boris Khusid Manufacture of fine particles and nano particles and coating thereof
WO2008135828A2 (fr) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules comprenant un médicament, de l'éthylcellulose et un sel biliaire
WO2008135855A2 (fr) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
EP2162120B1 (fr) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticules comportant un polymère cellulosique non ionisable et un copolymère bloc amphiphile non ionisable
EP2060268A1 (fr) * 2007-11-15 2009-05-20 Novo Nordisk A/S Compositions pharmaceutiques pour distribution pulmonaire ou nasale de peptides
EP2231169B1 (fr) 2007-12-06 2016-05-04 Bend Research, Inc. Compositions pharmaceutiques comprenant des nanoparticules et une matière de remise en suspension
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
EP2448571B1 (fr) 2010-08-30 2013-06-12 Pulmatrix, Inc. Poudre sèche respirable contenant du lactate de sodium, du chlorure de sodium et de la leucine
AU2011308865B2 (en) 2010-09-29 2017-01-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
NZ629722A (en) 2012-02-29 2017-03-31 Pulmatrix Operating Co Inc Inhalable dry powders
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
US6007845A (en) * 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5702717A (en) 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
DE69829204T2 (de) 1997-10-03 2005-12-15 Macromed Inc., Salt Lake City Biologisch abbaubare triblock-poly(lactide-co-glycolide)-polyethylenglycol-copolymere mit umgekehrter thermischer gelierung

Also Published As

Publication number Publication date
WO2002005730A1 (fr) 2002-01-24
US6669959B1 (en) 2003-12-30

Similar Documents

Publication Publication Date Title
EP1361860A4 (fr) Particules a liberation modulee d'administration d'un aerosol
EP1361857A4 (fr) Particules a liberation regulee pour aerosols
EP1361858A4 (fr) Particules a liberation controlee pour administration par aerosol
AU2001273629A1 (en) Modulated release particles for lung delivery
EP1361859A4 (fr) Particules a liberation modulee pour distribution en aerosol
AU2001289927A1 (en) Composite particles
WO2002000192A8 (fr) Embolisation a l'aide de particules revetues de carbone
AU2001288388A1 (en) Substance delivery system
AU2002223028A1 (en) Inhaler
AU2001248673A1 (en) Nasal inhaler
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2001292381A1 (en) Condensation particle counter
AU1995800A (en) Particle manipulation
AU2001280481A1 (en) A particle perfume delivery system
AU2001240581A1 (en) Inhalation nebulizer
AU2001283359A1 (en) Drug release (delivery system)
AUPQ912000A0 (en) Improved virus like particles
EP1361861A4 (fr) Particules a liberation modulee destinees a diffuser des aerosols
AU2001264789A1 (en) Protein powder for pulmonary delivery
AU2001268750A1 (en) Flushed-seal respirator
AU2002222145A1 (en) Particulate inhalation carrier
EP1361898A4 (fr) Particules a liberation prolongee pour administration par aerosol
AU2001283862A1 (en) Bvdv virus-like particles
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU2001290678A1 (en) Alginate particle formulation